122 related articles for article (PubMed ID: 12370743)
1. Immunohistological analysis of immune cell infiltration of a human colon tumor xenograft after treatment with Stealth liposome-encapsulated tumor necrosis factor-alpha and radiation.
Kim DW; Andres ML; Miller GM; Cao JD; Green LM; Seynhaeve AL; Ten Hagen TL; Gridley DS
Int J Oncol; 2002 Nov; 21(5):973-9. PubMed ID: 12370743
[TBL] [Abstract][Full Text] [Related]
2. Modulation of innate immunological factors by STEALTH liposome-encapsulated tumor necrosis factor-alpha in a colon tumor xenograft model.
Kim DW; Andres ML; Kajioka EH; Dutta-Roy R; Miller GM; Seynhaeve AL; ten Hagen TL; Gridley DS
Anticancer Res; 2002; 22(2A):777-88. PubMed ID: 12014650
[TBL] [Abstract][Full Text] [Related]
3. Liposome-encapsulated tumor necrosis factor-alpha enhances the effects of radiation against human colon tumor xenografts.
Kim DW; Andres ML; Li J; Kajioka EH; Miller GM; Seynhaeve AL; Ten Hagen TL; Gridley DS
J Interferon Cytokine Res; 2001 Nov; 21(11):885-97. PubMed ID: 11747620
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha augments radiation effects against human colon tumor xenografts.
Gridley DS; Hammond SN; Liwnicz BH
Anticancer Res; 1994; 14(3A):1107-12. PubMed ID: 8074459
[TBL] [Abstract][Full Text] [Related]
5. Combination of pGL1-TNF-alpha gene and radiation (proton and gamma-ray) therapy against brain tumor.
Gridley DS; Li J; Kajioka EH; Andres ML; Moyers MF; Slater JM
Anticancer Res; 2000; 20(6B):4195-203. PubMed ID: 11205248
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alpha enhances antitumor effects of radiation against glioma xenografts.
Gridley DS; Archambeau JO; Andres MA; Mao XW; Wright K; Slater JM
Oncol Res; 1997; 9(5):217-27. PubMed ID: 9306429
[TBL] [Abstract][Full Text] [Related]
7. Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes.
Huang SK; Stauffer PR; Hong K; Guo JW; Phillips TL; Huang A; Papahadjopoulos D
Cancer Res; 1994 Apr; 54(8):2186-91. PubMed ID: 8174126
[TBL] [Abstract][Full Text] [Related]
8. TNF-alpha gene and proton radiotherapy in an orthotopic brain tumor model.
Gridley DS; Baer JR; Cao JD; Miller GM; Kim DW; Timiryasova TM; Fodor I; Slater JM
Int J Oncol; 2002 Aug; 21(2):251-9. PubMed ID: 12118318
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative and cytotoxic effects of single and combined treatment with tumor necrosis factor alpha and/or alpha interferon on a human renal cell carcinoma xenotransplanted into nu/nu mice: cell kinetic studies.
Baisch H; Otto U; Klöppel G
Cancer Res; 1990 Oct; 50(19):6389-95. PubMed ID: 2400997
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma.
Huang SK; Mayhew E; Gilani S; Lasic DD; Martin FJ; Papahadjopoulos D
Cancer Res; 1992 Dec; 52(24):6774-81. PubMed ID: 1458465
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of TNF-alpha effects on radiation efficacy in a human lung adenocarcinoma model.
Gridley DS; Andres ML; Garner C; Mao XW; Slater JM
Oncol Res; 1996; 8(12):485-95. PubMed ID: 9160352
[TBL] [Abstract][Full Text] [Related]
12. Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway.
Zins K; Abraham D; Sioud M; Aharinejad S
Cancer Res; 2007 Feb; 67(3):1038-45. PubMed ID: 17283136
[TBL] [Abstract][Full Text] [Related]
13. Activated natural killer cell tumor retention and cytokine production in colon tumor using a tissue-isolated model.
Ribeiro U; Whiteside TL; Basse PH; Safatle-Ribeiro AV; Huneke CE; Posner MC
J Surg Res; 1999 Mar; 82(1):78-87. PubMed ID: 10068530
[TBL] [Abstract][Full Text] [Related]
14. Interaction of tumour necrosis factor-alpha and radiation against human colon tumour cells.
Gridley DS; Glisson WC; Uhm JR
Ther Immunol; 1994 Jan; 1(1):25-31. PubMed ID: 7584476
[TBL] [Abstract][Full Text] [Related]
15. Radiocurability by targeting tumor necrosis factor-alpha using a bispecific antibody in carcinoembryonic antigen transgenic mice.
Larbouret C; Robert B; Linard C; Teulon I; Gourgou S; Bibeau F; Martineau P; Santoro L; Pouget JP; Pelegrin A; Azria D
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1231-7. PubMed ID: 17967312
[TBL] [Abstract][Full Text] [Related]
16. Genetic radiotherapy overcomes tumor resistance to cytotoxic agents.
Seung LP; Mauceri HJ; Beckett MA; Hallahan DE; Hellman S; Weichselbaum RR
Cancer Res; 1995 Dec; 55(23):5561-5. PubMed ID: 7585635
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of tumors to synthesize tumor necrosis factor-alpha in situ using 5,6-dimethylxanthenone-4-acetic acid: a novel approach to cancer therapy.
Joseph WR; Cao Z; Mountjoy KG; Marshall ES; Baguley BC; Ching LM
Cancer Res; 1999 Feb; 59(3):633-8. PubMed ID: 9973211
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory and toxic effects of free and liposome-encapsulated tumor necrosis factor alpha in rats.
Debs RJ; Fuchs HJ; Philip R; Brunette EN; Düzgüneş N; Shellito JE; Liggitt D; Patton JR
Cancer Res; 1990 Jan; 50(2):375-80. PubMed ID: 2295077
[TBL] [Abstract][Full Text] [Related]
19. Combined alpha tumor necrosis factor gene therapy and engineered dendritic cell vaccine in combating well-established tumors.
Liu Y; Saxena A; Zheng C; Carlsen S; Xiang J
J Gene Med; 2004 Aug; 6(8):857-68. PubMed ID: 15293344
[TBL] [Abstract][Full Text] [Related]
20. Anti-proliferative and cytokinetic effects of tumor necrosis factor-alpha, interferon-alpha and 5-fluorouracil on a human tumor xenograft.
Tanaka N; Kojima K; Muro M; Naomoto Y; Moreira LF; Orita K
Anticancer Res; 1995; 15(5B):1949-52. PubMed ID: 8572582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
